Neurocrine Biosciences Inc (NBIX) · Insider trading

What Neurocrine Biosciences's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months

0 insiders, 0 trades

Sold, 12 months

$77.87M

15 insiders, 100% under a plan

Net, 12 months

−$77.87M

bought less sold

Latest filing

2026-09-15

filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

Bought Sold Largest month: $43.45M

Who traded, two years

Insider	Bought	Sold	Trades	Last trade	Holds after
Gorman Kevin CharlesDirector	–	$75.62M	8	2026-05-19	511,293
Gano KyleDirector, Chief Executive Officer	–	$14.72M	9	2026-01-16	140,407
Onyia JudeChief Scientific Officer	–	$14.58M	8	2026-06-01	25,846
Cooke JulieChief Human Resources Officer	–	$6.30M	10	2026-06-02	45,097
Rastetter William HDirector	–	$6.04M	2	2025-11-05	40,360
Sherwin Stephen ADirector	–	$5.75M	6	2026-06-05	32,977
Lippoldt DarinChief Legal Officer	–	$4.75M	9	2026-07-09	54,729
Delaet IngridChief Regulatory Officer	–	$4.32M	12	2026-07-10	16,225
Pops Richard FDirector	–	$2.36M	1	2026-05-15	34,480
Lyons Gary ADirector	–	$2.29M	1	2025-12-03	120,482
Morrow George JDirector	–	$2.15M	1	2025-11-25	7,068
Norwalk Leslie VDirector	–	$1.97M	5	2026-07-28	1,588
Benevich EricChief Commercial Officer	–	$1.79M	6	2026-09-09	64,408
Boyer David W.Chief Corp. Affairs Officer	–	$1.20M	6	2026-09-14	8,722
Abernethy MattChief Financial Officer	–	$974,252	5	2026-09-14	42,808
Roberts EiryChief Medical Officer	–	$596,743	5	2025-02-14	35,640

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

Date	Insider	Trade	Shares	Price	Value	Holds after	Filing
2026-09-14	Abernethy MattChief Financial Officer	Saleplan	2,311	157.20	$363,289	42,808	Form 4
2026-09-14	Boyer David W.Chief Corp. Affairs Officer	Saleplan	826	157.45	$130,054	8,722	Form 4
2026-09-09	Benevich EricChief Commercial Officer	Saleplan	2,154	154.61	$333,030	64,408	Form 4
2026-07-28	Norwalk Leslie VDirector	Saleplan	1,250	182.01	$227,512	1,588	Form 4
2026-07-10	Delaet IngridChief Regulatory Officer	Saleplan	4,367	181.02	$790,514	16,225	Form 4
2026-07-09	Lippoldt DarinChief Legal Officer	Saleplan	10,000	179.60	$1.80M	54,729	Form 4
2026-07-09	Delaet IngridChief Regulatory Officer	Saleplan	8,433	178.72	$1.51M	16,225	Form 4
2026-07-08	Delaet IngridChief Regulatory Officer	Saleplan	2,737	178.54	$488,664	16,225	Form 4
2026-07-07	Delaet IngridChief Regulatory Officer	Saleplan	3,401	178.57	$607,317	16,225	Form 4
2026-06-29	Lippoldt DarinChief Legal Officer	Saleplan	8,110	170.03	$1.38M	54,729	Form 4
2026-06-29	Lippoldt DarinChief Legal Officer	Saleplan	1,690	170.81	$288,669	54,729	Form 4
2026-06-26	Lippoldt DarinChief Legal Officer	Saleplan	200	169.57	$33,914	54,729	Form 4
2026-06-05	Sherwin Stephen ADirector	Saleplan	7,883	163.81	$1.29M	32,977	Form 4
2026-06-05	Sherwin Stephen ADirector	Saleplan	2,549	164.44	$419,158	30,428	Form 4
2026-06-05	Sherwin Stephen ADirector	Saleplan	6,896	165.79	$1.14M	23,532	Form 4
2026-06-05	Sherwin Stephen ADirector	Saleplan	5,829	166.56	$970,878	17,703	Form 4
2026-06-05	Sherwin Stephen ADirector	Saleplan	1,843	167.31	$308,352	15,860	Form 4
2026-06-04	Norwalk Leslie VDirector	Saleplan	1,250	168.06	$210,075	2,838	Form 4
2026-06-02	Cooke JulieChief Human Resources Officer	Saleplan	14,214	154.83	$2.20M	45,097	Form 4
2026-06-02	Cooke JulieChief Human Resources Officer	Saleplan	5,466	155.46	$849,744	39,631	Form 4
2026-06-02	Cooke JulieChief Human Resources Officer	Saleplan	4,216	156.77	$660,942	35,415	Form 4
2026-06-02	Cooke JulieChief Human Resources Officer	Saleplan	9,521	157.62	$1.50M	25,894	Form 4
2026-06-02	Cooke JulieChief Human Resources Officer	Saleplan	3,520	158.59	$558,237	22,374	Form 4
2026-06-01	Onyia JudeChief Scientific Officer	Saleplan	11,000	160.25	$1.76M	25,846	Form 4
2026-05-29	Delaet IngridChief Regulatory Officer	Saleplan	2,261	156.71	$354,321	16,225	Form 4
2026-05-27	Onyia JudeChief Scientific Officer	Saleplan	11,000	155.53	$1.71M	25,846	Form 4
2026-05-26	Boyer David W.Chief Corp. Affairs Officer	Saleplan	3,888	156.64	$609,016	7,799	Form 4
2026-05-19	Gorman Kevin CharlesDirector	Saleplan	245,088	154.33	$37.82M	511,293	Form 4
2026-05-15	Pops Richard FDirector	Saleplan	15,000	157.65	$2.36M	34,480	Form 4
2026-05-12	Norwalk Leslie VDirector	Saleplan	3,810	155.01	$590,588	2,429	Form 4
2026-01-16	Gano KyleDirector, Chief Executive Officer	Saleplan	34,588	132.70	$4.59M	140,407	Form 4
2026-01-16	Gano KyleDirector, Chief Executive Officer	Saleplan	1,812	132.71	$240,471	140,407	Form 4
2025-12-16	Norwalk Leslie VDirector	Saleplan	1,190	155.09	$184,557	6,239	Form 4
2025-12-15	Norwalk Leslie VDirector	Saleplan	5,000	152.23	$761,150	7,429	Form 4
2025-12-08	Lippoldt DarinChief Legal Officer	Saleplan	4,376	159.65	$698,628	43,405	Form 4
2025-12-03	Lyons Gary ADirector	Saleplan	15,000	152.61	$2.29M	120,482	Form 4
2025-11-28	Benevich EricChief Commercial Officer	Saleplan	5,970	151.74	$905,888	44,893	Form 4
2025-11-25	Morrow George JDirector	Saleplan	15,000	143.37	$2.15M	7,068	Form 4
2025-11-05	Rastetter William HDirector	Saleplan	18,000	151.82	$2.73M	40,360	Form 4
2025-11-04	Gano KyleDirector, Chief Executive Officer	Sale	300	141.97	$42,591	140,407	Form 4

54 more

2025-08-07	Gorman Kevin CharlesDirector	Saleplan	106,322	126.41	$13.44M	514,596	Form 4
2025-07-10	Delaet IngridChief Regulatory Officer	Saleplan	457	135.00	$61,695	4,730	Form 4
2025-07-09	Onyia JudeChief Scientific Officer	Saleplan	59,819	130.46	$7.80M	18,289	Form 4
2025-07-02	Onyia JudeChief Scientific Officer	Saleplan	20,362	130.13	$2.65M	18,289	Form 4
2025-05-27	Gorman Kevin CharlesDirector	Saleplan	9,613	120.38	$1.16M	514,596	Form 4
2025-05-05	Rastetter William HDirector	Saleplan	30,000	110.20	$3.31M	37,491	Form 4
2025-02-14	Roberts EiryChief Medical Officer	Saleplan	500	115.04	$57,520	35,640	Form 4
2025-02-13	Abernethy MattChief Financial Officer	Saleplan	1,352	116.85	$157,981	34,775	Form 4
2025-02-13	Abernethy MattChief Financial Officer	Saleplan	1,206	116.87	$140,945	35,810	Form 4
2025-02-13	Benevich EricChief Commercial Officer	Saleplan	1,098	116.74	$128,181	43,784	Form 4
2025-02-13	Benevich EricChief Commercial Officer	Saleplan	1,056	116.71	$123,246	44,689	Form 4
2025-02-13	Boyer David W.Chief Corp. Affairs Officer	Saleplan	955	116.79	$111,534	2,854	Form 4
2025-02-13	Boyer David W.Chief Corp. Affairs Officer	Saleplan	830	116.69	$96,853	3,565	Form 4
2025-02-13	Delaet IngridChief Regulatory Officer	Saleplan	716	116.69	$83,550	4,084	Form 4
2025-02-13	Delaet IngridChief Regulatory Officer	Saleplan	755	116.72	$88,124	4,730	Form 4
2025-02-13	Gano KyleDirector, Chief Executive Officer	Saleplan	1,352	116.84	$157,968	138,872	Form 4
2025-02-13	Gano KyleDirector, Chief Executive Officer	Saleplan	1,206	116.86	$140,933	139,907	Form 4
2025-02-13	Lippoldt DarinChief Legal Officer	Saleplan	1,098	116.76	$128,202	42,474	Form 4
2025-02-13	Lippoldt DarinChief Legal Officer	Saleplan	1,086	116.75	$126,790	43,405	Form 4
2025-02-13	Onyia JudeChief Scientific Officer	Saleplan	1,432	116.83	$167,301	16,846	Form 4
2025-02-13	Onyia JudeChief Scientific Officer	Saleplan	1,447	116.75	$168,937	18,089	Form 4
2025-02-13	Roberts EiryChief Medical Officer	Saleplan	1,114	116.90	$130,227	34,252	Form 4
2025-02-13	Roberts EiryChief Medical Officer	Saleplan	604	116.74	$70,511	34,768	Form 4
2025-02-13	Sherwin Stephen ADirector	Saleplan	13,831	116.69	$1.61M	10,673	Form 4
2025-02-13	Gorman Kevin CharlesDirector	Saleplan	2,832	116.69	$330,466	521,618	Form 4
2025-02-13	Gorman Kevin CharlesDirector	Saleplan	3,012	116.68	$351,440	524,209	Form 4
2025-02-13	Cooke JulieChief Human Resources Officer	Saleplan	796	116.77	$92,949	19,544	Form 4
2025-02-13	Cooke JulieChief Human Resources Officer	Saleplan	755	116.80	$88,184	20,190	Form 4
2025-02-10	Abernethy MattChief Financial Officer	Saleplan	980	118.27	$115,905	33,561	Form 4
2025-02-10	Benevich EricChief Commercial Officer	Saleplan	980	118.31	$115,944	42,799	Form 4
2025-02-10	Boyer David W.Chief Corp. Affairs Officer	Saleplan	700	118.31	$82,817	1,998	Form 4
2025-02-10	Gano KyleDirector, Chief Executive Officer	Saleplan	980	118.39	$116,022	137,658	Form 4
2025-02-10	Lippoldt DarinChief Legal Officer	Saleplan	911	118.25	$107,726	41,679	Form 4
2025-02-10	Roberts EiryChief Medical Officer	Saleplan	980	118.22	$115,856	33,253	Form 4
2025-02-10	Gorman Kevin CharlesDirector	Saleplan	2,274	118.37	$269,173	519,074	Form 4
2025-02-10	Cooke JulieChief Human Resources Officer	Saleplan	700	118.28	$82,796	18,831	Form 4
2025-02-03	Delaet IngridChief Regulatory Officer	Saleplan	623	149.29	$93,008	3,442	Form 4
2025-01-31	Abernethy MattChief Financial Officer	Saleplan	1,283	152.87	$196,132	32,681	Form 4
2025-01-31	Benevich EricChief Commercial Officer	Saleplan	1,207	152.94	$184,599	41,919	Form 4
2025-01-31	Boyer David W.Chief Corp. Affairs Officer	Saleplan	1,104	152.94	$168,846	1,369	Form 4
2025-01-31	Delaet IngridChief Regulatory Officer	Saleplan	422	153.05	$64,587	2,886	Form 4
2025-01-31	Gano KyleDirector, Chief Executive Officer	Saleplan	1,541	152.87	$235,573	136,778	Form 4
2025-01-31	Lippoldt DarinChief Legal Officer	Saleplan	1,250	152.91	$191,138	40,863	Form 4
2025-01-31	Onyia JudeChief Scientific Officer	Saleplan	126	152.97	$19,274	15,561	Form 4
2025-01-31	Roberts EiryChief Medical Officer	Saleplan	1,457	152.80	$222,630	32,373	Form 4
2025-01-31	Gorman Kevin CharlesDirector	Saleplan	2,707	152.92	$413,954	517,030	Form 4
2025-01-31	Cooke JulieChief Human Resources Officer	Saleplan	916	152.89	$140,047	19,026	Form 4
2025-01-31	Cooke JulieChief Human Resources Officer	Saleplan	824	152.89	$125,981	18,202	Form 4
2025-01-27	Gorman Kevin CharlesDirector	Saleplan	146,105	149.46	$21.84M	514,596	Form 4
2025-01-15	Gano KyleDirector, Chief Executive Officer	Saleplan	4,812	141.50	$680,898	135,392	Form 4
2025-01-15	Gano KyleDirector, Chief Executive Officer	Saleplan	60,188	141.50	$8.52M	135,392	Form 4
2024-12-31	Delaet IngridChief Regulatory Officer	Saleplan	272	138.10	$37,563	2,507	Form 4
2024-12-17	Delaet IngridChief Regulatory Officer	Saleplan	1,091	135.00	$147,285	2,507	Form 4
2024-11-29	Onyia JudeChief Scientific Officer	Saleplan	2,331	126.29	$294,382	15,449	Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

140 × option exercise57 × shares withheld for tax20 × grant or award11 × gift

Show them

Date	Insider	What	Shares	Price	Holds after	Filing
2026-09-11	Gorman Kevin CharlesDirector	Grant or award A	+14,343	–	525,636	Form 4
2026-09-11	Gorman Kevin CharlesDirector	Shares withheld for tax F	−7,839	156.22	517,797	Form 4
2026-09-11	Lippoldt DarinChief Legal Officer	Grant or award A	+4,483	–	59,212	Form 4
2026-09-11	Lippoldt DarinChief Legal Officer	Shares withheld for tax F	−2,419	156.22	56,793	Form 4
2026-09-11	Gano KyleDirector, Chief Executive Officer	Grant or award A	+6,275	–	157,266	Form 4
2026-09-11	Gano KyleDirector, Chief Executive Officer	Shares withheld for tax F	−3,386	156.22	153,880	Form 4
2026-09-11	Gano KyleDirector, Chief Executive Officer	Grant or award A	+1,842	–	155,722	Form 4
2026-09-11	Gano KyleDirector, Chief Executive Officer	Shares withheld for tax F	−994	156.22	154,728	Form 4
2026-09-11	Benevich EricChief Commercial Officer	Grant or award A	+6,275	–	70,683	Form 4
2026-09-11	Benevich EricChief Commercial Officer	Shares withheld for tax F	−3,386	156.22	67,297	Form 4
2026-09-11	Abernethy MattChief Financial Officer	Grant or award A	+5,020	–	47,828	Form 4
2026-09-11	Abernethy MattChief Financial Officer	Shares withheld for tax F	−2,709	156.22	45,119	Form 4
2026-09-11	Cooke JulieChief Human Resources Officer	Grant or award A	+3,587	–	25,961	Form 4
2026-09-11	Cooke JulieChief Human Resources Officer	Shares withheld for tax F	−1,936	156.22	24,025	Form 4
2026-09-11	Keswani Sanjay ChandruChief Medical Officer	Grant or award A	+3,914	–	5,393	Form 4
2026-09-11	Keswani Sanjay ChandruChief Medical Officer	Shares withheld for tax F	−2,112	156.22	3,281	Form 4
2026-09-11	Onyia JudeChief Scientific Officer	Grant or award A	+3,587	–	24,583	Form 4
2026-09-11	Onyia JudeChief Scientific Officer	Shares withheld for tax F	−1,936	156.22	22,647	Form 4
2026-09-11	Boyer David W.Chief Corp. Affairs Officer	Grant or award A	+3,587	–	11,484	Form 4
2026-09-11	Boyer David W.Chief Corp. Affairs Officer	Shares withheld for tax F	−1,936	156.22	9,548	Form 4
2026-09-11	Delaet IngridChief Regulatory Officer	Grant or award A	+4,483	–	20,708	Form 4
2026-09-11	Delaet IngridChief Regulatory Officer	Shares withheld for tax F	−2,419	156.22	18,289	Form 4
2026-09-09	Benevich EricChief Commercial Officer	Option exercise M	+3,194	43.24	66,562	Form 4
2026-09-02	Sherwin Stephen ADirector	Gift G	−1,000	–	14,860	Form 4
2026-08-04	Onyia JudeChief Scientific Officer	Gift G	−2,409	–	20,996	Form 4
2026-07-29	Norwalk Leslie VDirector	Option exercise M	+842	139.43	2,430	Form 4
2026-07-10	Delaet IngridChief Regulatory Officer	Option exercise M	+4,367	106.02	20,592	Form 4
2026-07-09	Lippoldt DarinChief Legal Officer	Option exercise M	+10,000	81.49	64,729	Form 4
2026-07-09	Delaet IngridChief Regulatory Officer	Option exercise M	+8,433	103.52	24,658	Form 4
2026-07-08	Delaet IngridChief Regulatory Officer	Option exercise M	+2,737	103.52	18,962	Form 4
2026-07-07	Delaet IngridChief Regulatory Officer	Option exercise M	+3,401	103.52	19,626	Form 4
2026-06-29	Lippoldt DarinChief Legal Officer	Option exercise M	+8,110	81.49	62,839	Form 4
2026-06-29	Lippoldt DarinChief Legal Officer	Option exercise M	+1,690	81.49	56,419	Form 4
2026-06-26	Lippoldt DarinChief Legal Officer	Option exercise M	+200	81.49	54,929	Form 4
2026-06-05	Sherwin Stephen ADirector	Option exercise M	+15,000	53.64	30,860	Form 4
2026-06-05	Sherwin Stephen ADirector	Option exercise M	+10,000	79.79	40,860	Form 4
2026-06-05	Onyia JudeChief Scientific Officer	Gift G	−2,441	–	23,405	Form 4
2026-06-02	Cooke JulieChief Human Resources Officer	Option exercise M	+24,965	81.49	59,311	Form 4
2026-06-02	Keswani Sanjay ChandruChief Medical Officer	Option exercise M	+3,212	–	3,212	Form 4
2026-06-02	Keswani Sanjay ChandruChief Medical Officer	Shares withheld for tax F	−1,733	154.84	1,479	Form 4
2026-06-01	Onyia JudeChief Scientific Officer	Option exercise M	+11,000	84.74	36,846	Form 4
2026-05-29	Delaet IngridChief Regulatory Officer	Option exercise M	+2,261	79.02	18,486	Form 4
2026-05-27	Onyia JudeChief Scientific Officer	Option exercise M	+11,000	84.74	36,846	Form 4
2026-05-21	Morrow George JDirector	Option exercise M	+3,318	–	10,386	Form 4
2026-05-21	Sherwin Stephen ADirector	Option exercise M	+3,318	–	15,860	Form 4
2026-05-21	Lyons Gary ADirector	Option exercise M	+1,659	–	122,141	Form 4
2026-05-21	Pops Richard FDirector	Option exercise M	+3,318	–	37,798	Form 4
2026-05-21	Poon Christine ADirector	Option exercise M	+3,318	–	4,753	Form 4
2026-05-21	Rastetter William HDirector	Option exercise M	+3,318	–	43,678	Form 4
2026-05-21	Sharp ShaliniDirector	Option exercise M	+1,659	–	4,088	Form 4
2026-05-21	Norwalk Leslie VDirector	Option exercise M	+1,659	–	4,088	Form 4
2026-05-21	Mercier JohannaDirector	Option exercise M	+3,318	–	6,853	Form 4
2026-05-19	Gorman Kevin CharlesDirector	Option exercise M	+205,088	43.24	756,381	Form 4
2026-05-15	Pops Richard FDirector	Option exercise M	+15,000	47.89	49,480	Form 4
2026-03-04	Abernethy MattChief Financial Officer	Gift G	−2,249	–	42,808	Form 4
2026-02-20	Onyia JudeChief Scientific Officer	Gift G	−3,110	–	25,670	Form 4
2026-02-13	Gorman Kevin CharlesDirector	Option exercise M	+5,604	–	522,497	Form 4
2026-02-13	Gorman Kevin CharlesDirector	Shares withheld for tax F	−3,024	124.12	519,473	Form 4
2026-02-13	Gorman Kevin CharlesDirector	Option exercise M	+5,377	–	524,850	Form 4
2026-02-13	Gorman Kevin CharlesDirector	Shares withheld for tax F	−2,901	124.12	521,949	Form 4
2026-02-13	Gorman Kevin CharlesDirector	Grant or award A	+63,724	–	585,673	Form 4
2026-02-13	Gorman Kevin CharlesDirector	Shares withheld for tax F	−34,380	124.12	551,293	Form 4
2026-02-13	Lippoldt DarinChief Legal Officer	Option exercise M	+2,017	–	50,634	Form 4
2026-02-13	Lippoldt DarinChief Legal Officer	Shares withheld for tax F	−1,089	124.12	49,545	Form 4
2026-02-13	Lippoldt DarinChief Legal Officer	Option exercise M	+2,083	–	51,628	Form 4
2026-02-13	Lippoldt DarinChief Legal Officer	Shares withheld for tax F	−1,124	124.12	50,504	Form 4
2026-02-13	Lippoldt DarinChief Legal Officer	Grant or award A	+9,968	–	60,472	Form 4
2026-02-13	Lippoldt DarinChief Legal Officer	Shares withheld for tax F	−5,378	124.12	55,094	Form 4
2026-02-13	Lippoldt DarinChief Legal Officer	Gift G	−365	–	54,729	Form 4
2026-02-13	Gano KyleDirector, Chief Executive Officer	Option exercise M	+2,241	–	146,254	Form 4
2026-02-13	Gano KyleDirector, Chief Executive Officer	Shares withheld for tax F	−1,210	124.12	145,044	Form 4
2026-02-13	Gano KyleDirector, Chief Executive Officer	Option exercise M	+2,566	–	147,610	Form 4
2026-02-13	Gano KyleDirector, Chief Executive Officer	Shares withheld for tax F	−1,385	124.12	146,225	Form 4
2026-02-13	Gano KyleDirector, Chief Executive Officer	Grant or award A	+9,968	–	156,193	Form 4
2026-02-13	Gano KyleDirector, Chief Executive Officer	Shares withheld for tax F	−5,378	124.12	150,815	Form 4
2026-02-13	Benevich EricChief Commercial Officer	Option exercise M	+1,961	–	55,639	Form 4
2026-02-13	Benevich EricChief Commercial Officer	Shares withheld for tax F	−1,058	124.12	54,581	Form 4
2026-02-13	Benevich EricChief Commercial Officer	Option exercise M	+2,083	–	56,664	Form 4
2026-02-13	Benevich EricChief Commercial Officer	Shares withheld for tax F	−1,124	124.12	55,540	Form 4
2026-02-13	Benevich EricChief Commercial Officer	Grant or award A	+16,613	–	72,153	Form 4
2026-02-13	Benevich EricChief Commercial Officer	Shares withheld for tax F	−8,963	124.12	63,190	Form 4
2026-02-13	Abernethy MattChief Financial Officer	Option exercise M	+2,241	–	40,320	Form 4
2026-02-13	Abernethy MattChief Financial Officer	Shares withheld for tax F	−1,210	124.12	39,110	Form 4
2026-02-13	Abernethy MattChief Financial Officer	Option exercise M	+2,566	–	41,676	Form 4
2026-02-13	Abernethy MattChief Financial Officer	Shares withheld for tax F	−1,385	124.12	40,291	Form 4
2026-02-13	Abernethy MattChief Financial Officer	Grant or award A	+9,968	–	50,259	Form 4
2026-02-13	Abernethy MattChief Financial Officer	Shares withheld for tax F	−5,378	124.12	44,881	Form 4
2026-02-13	Cooke JulieChief Human Resources Officer	Option exercise M	+1,401	–	29,641	Form 4
2026-02-13	Cooke JulieChief Human Resources Officer	Shares withheld for tax F	−756	124.12	28,885	Form 4
2026-02-13	Cooke JulieChief Human Resources Officer	Option exercise M	+1,510	–	30,395	Form 4
2026-02-13	Cooke JulieChief Human Resources Officer	Shares withheld for tax F	−815	124.12	29,580	Form 4
2026-02-13	Cooke JulieChief Human Resources Officer	Grant or award A	+9,968	–	39,548	Form 4
2026-02-13	Cooke JulieChief Human Resources Officer	Shares withheld for tax F	−5,378	124.12	34,170	Form 4
2026-02-13	Onyia JudeChief Scientific Officer	Option exercise M	+2,690	–	19,801	Form 4
2026-02-13	Onyia JudeChief Scientific Officer	Shares withheld for tax F	−1,452	124.12	18,349	Form 4
2026-02-13	Onyia JudeChief Scientific Officer	Option exercise M	+2,717	–	21,066	Form 4
2026-02-13	Onyia JudeChief Scientific Officer	Shares withheld for tax F	−1,466	124.12	19,600	Form 4
2026-02-13	Onyia JudeChief Scientific Officer	Grant or award A	+19,935	–	39,535	Form 4
2026-02-13	Onyia JudeChief Scientific Officer	Shares withheld for tax F	−10,755	124.12	28,780	Form 4
2026-02-13	Boyer David W.Chief Corp. Affairs Officer	Option exercise M	+1,541	–	6,990	Form 4
2026-02-13	Boyer David W.Chief Corp. Affairs Officer	Shares withheld for tax F	−832	124.12	6,158	Form 4
2026-02-13	Boyer David W.Chief Corp. Affairs Officer	Option exercise M	+1,811	–	7,969	Form 4
2026-02-13	Boyer David W.Chief Corp. Affairs Officer	Shares withheld for tax F	−978	124.12	6,991	Form 4
2026-02-13	Boyer David W.Chief Corp. Affairs Officer	Grant or award A	+9,968	–	16,959	Form 4
2026-02-13	Boyer David W.Chief Corp. Affairs Officer	Shares withheld for tax F	−5,378	124.12	11,581	Form 4
2026-02-13	Delaet IngridChief Regulatory Officer	Option exercise M	+1,401	–	7,176	Form 4
2026-02-13	Delaet IngridChief Regulatory Officer	Shares withheld for tax F	−756	124.12	6,420	Form 4
2026-02-13	Delaet IngridChief Regulatory Officer	Option exercise M	+1,359	–	7,779	Form 4
2026-02-13	Delaet IngridChief Regulatory Officer	Shares withheld for tax F	−734	124.12	7,045	Form 4
2026-02-13	Delaet IngridChief Regulatory Officer	Grant or award A	+19,935	–	26,980	Form 4
2026-02-13	Delaet IngridChief Regulatory Officer	Shares withheld for tax F	−10,755	124.12	16,225	Form 4
2026-02-12	Lippoldt DarinChief Legal Officer	Option exercise M	+1,792	–	49,584	Form 4
2026-02-12	Lippoldt DarinChief Legal Officer	Shares withheld for tax F	−967	123.10	48,617	Form 4
2026-02-12	Gano KyleDirector, Chief Executive Officer	Option exercise M	+4,907	–	146,661	Form 4
2026-02-12	Gano KyleDirector, Chief Executive Officer	Shares withheld for tax F	−2,648	123.10	144,013	Form 4
2026-02-12	Benevich EricChief Commercial Officer	Option exercise M	+2,005	–	54,760	Form 4
2026-02-12	Benevich EricChief Commercial Officer	Shares withheld for tax F	−1,082	123.10	53,678	Form 4
2026-02-12	Abernethy MattChief Financial Officer	Option exercise M	+2,133	–	39,230	Form 4
2026-02-12	Abernethy MattChief Financial Officer	Shares withheld for tax F	−1,151	123.10	38,079	Form 4
2026-02-12	Cooke JulieChief Human Resources Officer	Option exercise M	+1,387	–	28,989	Form 4
2026-02-12	Cooke JulieChief Human Resources Officer	Shares withheld for tax F	−749	123.10	28,240	Form 4
2026-02-12	Onyia JudeChief Scientific Officer	Option exercise M	+2,560	–	18,537	Form 4
2026-02-12	Onyia JudeChief Scientific Officer	Shares withheld for tax F	−1,426	123.10	17,111	Form 4
2026-02-12	Boyer David W.Chief Corp. Affairs Officer	Option exercise M	+1,600	–	6,313	Form 4
2026-02-12	Boyer David W.Chief Corp. Affairs Officer	Shares withheld for tax F	−864	123.10	5,449	Form 4
2026-02-12	Delaet IngridChief Regulatory Officer	Option exercise M	+1,600	–	6,656	Form 4
2026-02-12	Delaet IngridChief Regulatory Officer	Shares withheld for tax F	−881	123.10	5,775	Form 4
2026-01-31	Gorman Kevin CharlesDirector	Option exercise M	+5,142	–	519,738	Form 4
2026-01-31	Gorman Kevin CharlesDirector	Shares withheld for tax F	−2,845	136.06	516,893	Form 4
2026-01-31	Lippoldt DarinChief Legal Officer	Option exercise M	+2,373	–	49,127	Form 4
2026-01-31	Lippoldt DarinChief Legal Officer	Shares withheld for tax F	−1,335	136.06	47,792	Form 4
2026-01-31	Gano KyleDirector, Chief Executive Officer	Option exercise M	+2,927	–	143,334	Form 4
2026-01-31	Gano KyleDirector, Chief Executive Officer	Shares withheld for tax F	−1,580	136.06	141,754	Form 4
2026-01-31	Benevich EricChief Commercial Officer	Option exercise M	+2,294	–	54,047	Form 4
2026-01-31	Benevich EricChief Commercial Officer	Shares withheld for tax F	−1,292	136.06	52,755	Form 4
2026-01-31	Abernethy MattChief Financial Officer	Option exercise M	+2,437	–	38,465	Form 4
2026-01-31	Abernethy MattChief Financial Officer	Shares withheld for tax F	−1,368	136.06	37,097	Form 4
2026-01-31	Cooke JulieChief Human Resources Officer	Option exercise M	+1,741	–	28,599	Form 4
2026-01-31	Cooke JulieChief Human Resources Officer	Shares withheld for tax F	−997	136.06	27,602	Form 4
2026-01-31	Onyia JudeChief Scientific Officer	Option exercise M	+238	–	16,119	Form 4
2026-01-31	Onyia JudeChief Scientific Officer	Shares withheld for tax F	−142	136.06	15,977	Form 4
2026-01-31	Boyer David W.Chief Corp. Affairs Officer	Option exercise M	+2,096	–	5,902	Form 4
2026-01-31	Boyer David W.Chief Corp. Affairs Officer	Shares withheld for tax F	−1,189	136.06	4,713	Form 4
2026-01-31	Delaet IngridChief Regulatory Officer	Option exercise M	+801	–	5,531	Form 4
2026-01-31	Delaet IngridChief Regulatory Officer	Shares withheld for tax F	−475	136.06	5,056	Form 4
2026-01-16	Gano KyleDirector, Chief Executive Officer	Option exercise M	+34,588	35.99	174,995	Form 4
2026-01-16	Gano KyleDirector, Chief Executive Officer	Option exercise M	+1,812	35.99	142,219	Form 4
2026-01-08	Lippoldt DarinChief Legal Officer	Option exercise M	+3,349	35.99	46,754	Form 4
2025-12-15	Norwalk Leslie VDirector	Option exercise M	+8,276	92.35	10,705	Form 4
2025-12-15	Norwalk Leslie VDirector	Option exercise M	+1,724	84.95	12,429	Form 4
2025-12-08	Lippoldt DarinChief Legal Officer	Option exercise M	+4,376	43.24	47,781	Form 4
2025-12-03	Lyons Gary ADirector	Option exercise M	+15,000	47.89	135,482	Form 4
2025-11-29	Onyia JudeChief Scientific Officer	Option exercise M	+4,426	–	18,129	Form 4
2025-11-29	Onyia JudeChief Scientific Officer	Shares withheld for tax F	−2,248	152.16	15,881	Form 4
2025-11-28	Benevich EricChief Commercial Officer	Option exercise M	+12,830	35.99	57,723	Form 4/A
2025-11-25	Morrow George JDirector	Option exercise M	+15,000	47.89	22,068	Form 4
2025-11-05	Rastetter William HDirector	Option exercise M	+18,000	47.89	58,360	Form 4
2025-11-01	Gano KyleDirector, Chief Executive Officer	Option exercise M	+613	–	140,720	Form 4
2025-09-03	Onyia JudeChief Scientific Officer	Gift G	−1,470	–	13,703	Form 4
2025-09-02	Sherwin Stephen ADirector	Gift G	−1,000	–	12,542	Form 4
2025-08-07	Gorman Kevin CharlesDirector	Option exercise M	+106,322	35.99	620,918	Form 4
2025-08-05	Onyia JudeChief Scientific Officer	Gift G	−3,116	–	15,173	Form 4
2025-07-10	Delaet IngridChief Regulatory Officer	Option exercise M	+457	79.02	5,187	Form 4
2025-07-09	Onyia JudeChief Scientific Officer	Option exercise M	+59,819	84.74	78,108	Form 4
2025-07-02	Onyia JudeChief Scientific Officer	Option exercise M	+20,362	84.74	38,651	Form 4
2025-05-22	Mercier JohannaDirector	Option exercise M	+1,435	–	3,535	Form 4
2025-05-22	Norwalk Leslie VDirector	Option exercise M	+1,435	–	2,429	Form 4
2025-05-22	Lyons Gary ADirector	Option exercise M	+1,435	–	120,482	Form 4
2025-05-22	Morrow George JDirector	Option exercise M	+2,869	–	7,068	Form 4
2025-05-22	Pops Richard FDirector	Option exercise M	+2,869	–	34,480	Form 4
2025-05-22	Sherwin Stephen ADirector	Option exercise M	+2,869	–	13,542	Form 4
2025-05-22	Sharp ShaliniDirector	Option exercise M	+1,435	–	2,429	Form 4
2025-05-22	Poon Christine ADirector	Option exercise M	+1,435	–	1,435	Form 4
2025-05-22	Rastetter William HDirector	Option exercise M	+2,869	–	40,360	Form 4
2025-05-16	Cooke JulieChief Human Resources Officer	Option exercise M	+6,468	61.82	26,858	Form 4
2025-05-05	Rastetter William HDirector	Option exercise M	+30,000	42.76	67,491	Form 4
2025-02-13	Abernethy MattChief Financial Officer	Option exercise M	+2,566	–	36,127	Form 4
2025-02-13	Abernethy MattChief Financial Officer	Option exercise M	+2,241	–	37,016	Form 4
2025-02-13	Benevich EricChief Commercial Officer	Option exercise M	+2,083	–	44,882	Form 4
2025-02-13	Benevich EricChief Commercial Officer	Option exercise M	+1,961	–	45,745	Form 4
2025-02-13	Boyer David W.Chief Corp. Affairs Officer	Option exercise M	+1,811	–	3,809	Form 4
2025-02-13	Boyer David W.Chief Corp. Affairs Officer	Option exercise M	+1,541	–	4,395	Form 4
2025-02-13	Delaet IngridChief Regulatory Officer	Option exercise M	+1,358	–	4,800	Form 4
2025-02-13	Delaet IngridChief Regulatory Officer	Option exercise M	+1,401	–	5,485	Form 4
2025-02-13	Gano KyleDirector, Chief Executive Officer	Option exercise M	+2,566	–	140,224	Form 4
2025-02-13	Gano KyleDirector, Chief Executive Officer	Option exercise M	+2,241	–	141,113	Form 4
2025-02-13	Lippoldt DarinChief Legal Officer	Option exercise M	+2,083	–	43,572	Form 4
2025-02-13	Lippoldt DarinChief Legal Officer	Option exercise M	+2,017	–	44,491	Form 4
2025-02-13	Onyia JudeChief Scientific Officer	Option exercise M	+2,717	–	18,278	Form 4
2025-02-13	Onyia JudeChief Scientific Officer	Option exercise M	+2,690	–	19,536	Form 4
2025-02-13	Roberts EiryChief Medical Officer	Option exercise M	+2,113	–	35,366	Form 4
2025-02-13	Roberts EiryChief Medical Officer	Option exercise M	+1,120	–	35,372	Form 4
2025-02-13	Roberts EiryChief Medical Officer	Option exercise M	+1,372	–	36,140	Form 4
2025-02-13	Gorman Kevin CharlesDirector	Option exercise M	+5,376	–	524,450	Form 4
2025-02-13	Gorman Kevin CharlesDirector	Option exercise M	+5,603	–	527,221	Form 4
2025-02-13	Cooke JulieChief Human Resources Officer	Option exercise M	+1,509	–	20,340	Form 4
2025-02-13	Cooke JulieChief Human Resources Officer	Option exercise M	+1,401	–	20,945	Form 4
2025-02-12	Lippoldt DarinChief Legal Officer	Gift G	−190	–	41,489	Form 4
2025-02-08	Abernethy MattChief Financial Officer	Option exercise M	+1,860	–	34,541	Form 4
2025-02-08	Benevich EricChief Commercial Officer	Option exercise M	+1,860	–	43,779	Form 4

How to read it

Buy, sale: Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan: A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after: The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value: Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Neurocrine Biosciences's scores and multiples ›